The Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure

This study has been completed.
Sponsor:
Information provided by:
Aristotle University Of Thessaloniki
ClinicalTrials.gov Identifier:
NCT01029860
First received: December 9, 2009
Last updated: December 16, 2009
Last verified: March 2007
  Purpose

The purpose of this study is to assess the effect of hospital admission on 24-hour ambulatory blood pressure (ABP) in hypertensive subjects.Treated or untreated hypertensive adults with open angle glaucoma underwent in-hospital and outpatient 24-hour ABP monitoring, in random order 4 weeks apart.


Condition
Blood Pressure

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: A Study Investigating the Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure in Subjects With Mild to Moderate Arterial Hypertension and Untreated Ocular Hypertension

Resource links provided by NLM:


Further study details as provided by Aristotle University Of Thessaloniki:

Enrollment: 40
Study Start Date: March 2007
Study Completion Date: March 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   30 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Subjects with untreated ocular hypertension and stage 1 arterial hypertension with or without treatment with anti-hypertensive agents.

Criteria

Inclusion Criteria:

  • age >30 years old.
  • subject has signed an informed consent.
  • patient has untreated ocular hypertension (IOP at 10:00 between 22-34 mm Hg)
  • patient has stage 1 arterial hypertension with or without therapy

Exclusion Criteria:

  • secondary hypertension.
  • stage 2 or 3 hypertension, history of renal disease.
  • sleep apnea.
  • diabetes mellitus
  • acute or chronic inflammation.
  • myocardial infarction or unstable angina within the past 6 months.
  • heart failure NYHA class III-IV.
  • active liver disease.
  • pregnancy.
  • history of drug or alcohol abuse, or any other condition with poor prognosis.
  • treatment with non-steroid anti-inflammatory agents, corticosteroids, beta-blockers, or any other regimen that could affect BP levels.
  • smoking
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Anastasios Lasaridis, 1st Department of Internal Medicine, Aristotle University, Thessaloniki
ClinicalTrials.gov Identifier: NCT01029860     History of Changes
Other Study ID Numbers: A3244
Study First Received: December 9, 2009
Last Updated: December 16, 2009
Health Authority: Greece: Ethics Committee

Keywords provided by Aristotle University Of Thessaloniki:
Hypertension
Ambulatory measurement

ClinicalTrials.gov processed this record on September 30, 2014